Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.4097
Delayed Data
As of 3:59pm ET
 +0.0098 / +2.45%
Today’s Change
0.33
Today|||52-Week Range
0.62
-2.52%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.40
Today’s open0.39
Day’s range0.39 - 0.42
Volume592,406
Average volume (3 months)1,245,273
Market cap$65.4M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+17.86%
Earnings growth (this year)--
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
SNSSSunesis Pharmaceutic...+0.02+3.28%
BOTABiota Pharmaceutical...-0.15-9.04%
APRIApricus Biosciences ...-0.03-2.50%
CERUCerulean Pharma Inc-0.04-1.72%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$28.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts

Partner Offers